INDRAPRASTHA MEDICAL Fact Sheet, INDRAPRASTHA MEDICAL Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Fact Sheet    (IRMED)


One Stock Crorepati: The Biggest Money-Making Opportunity Available Right Now

Here is the latest financial fact sheet of INDRAPRASTHA MEDICAL. For more details, see the INDRAPRASTHA MEDICAL quarterly results and INDRAPRASTHA MEDICAL share price and chart. For a sector overview, read our pharmaceuticals sector report.

INDRAPRASTHA MEDICAL Price History

Price Rs 34.8
Mkt Cap Rs m 3,190
Vol '000 19.8
P/E X 7.8
P/CF X 5.5
EPS (TTM) Rs 4.4
% ch % 1.5
No. of shares m 91.67
% ch week % 1.5
% ch 1-mth % -6.6
% ch 12-mth % -10.4
52 week H/L Rs 52.4/27.5
(As on Apr 9, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

INDRAPRASTHA MEDICAL Financials

No. of Mths
Year Ending
12
Mar-15
12
Mar-16
12
Mar-17
12
Mar-18
12
Mar-19
5-Yr Chart
Click to enlarge
INDRAPRASTHA MEDICAL EQUITY SHARE DATA
High RsNA77636952 
Low RsNA47454636 
Sales per share (Unadj.) Rs77.982.683.582.186.0 
Earnings per share (Unadj.) Rs3.53.12.92.33.1 
Diluted earnings per shareRs3.53.12.92.33.1 
Cash flow per share (Unadj.) Rs6.66.06.25.66.3 
Dividends per share (Unadj.) Rs1.801.801.801.501.60 
Adj. dividends per shareRs1.801.801.801.501.60 
Dividend yield (eoy) %NM2.93.32.63.6 
Book value per share (Unadj.) Rs21.222.225.225.326.6 
Adj. book value per shareRs21.222.225.225.326.6 
Shares outstanding (eoy) m91.6791.6791.6791.6791.67 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x00.70.60.70.5 
Avg P/E ratio x020.118.924.914.2 
P/CF ratio (eoy) x010.38.810.27.0 
Price / Book Value ratio x02.82.22.31.7 
Dividend payout %50.858.462.965.151.6 
Avg Mkt Cap Rs m05,6704,9695,2624,043 
No. of employees `0003.23.23.03.03.0 
Total wages/salary Rs m1,5581,8031,9021,9402,002 
Avg. sales/employee Rs Th2,218.12,404.92,581.72,493.12,608.1 
Avg. wages/employee Rs Th483.7572.5641.3642.6662.5 
Avg. net profit/employee Rs Th100.989.688.569.994.0 
INDRAPRASTHA MEDICAL INCOME DATA
Net Sales Rs m7,1457,5757,6577,5277,882 
Other income Rs m1021585 
Total revenues Rs m7,1547,5967,6627,5357,886 
Gross profit Rs m849763788728808 
Depreciation Rs m282266305307298 
Interest Rs m8173798969 
Profit before tax Rs m496445408340446 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m171163146129162 
Profit after tax Rs m325282262211284 
Gross profit margin %11.910.110.39.710.2 
Effective tax rate %34.436.535.737.936.3 
Net profit margin %4.53.73.42.83.6 
INDRAPRASTHA MEDICAL BALANCE SHEET DATA
Current assets Rs m1,4881,7041,5791,3291,356 
Current liabilities Rs m1,9402,1691,8571,3841,241 
Net working cap to sales %-6.3-6.1-3.6-0.71.5 
Current ratio x0.80.80.91.01.1 
Inventory Days Days66544 
Debtors Days Days4044474135 
Net fixed assets Rs m2,8872,9603,0052,9402,814 
Share capital Rs m917917917917917 
"Free" reserves Rs m1,0311,1151,3921,4061,524 
Net worth Rs m1,9482,0312,3082,3232,440 
Long term debt Rs m108250210150 
Total assets Rs m4,4164,6644,5844,3234,224 
Interest coverage x7.17.16.24.87.5 
Debt to equity ratio x0.1000.10.1 
Sales to assets ratio x1.61.61.71.71.9 
Return on assets %9.27.67.56.98.4 
Return on equity %16.713.911.49.111.6 
Return on capital %28.025.221.116.919.9 
Exports to sales %00000 
Imports to sales %2.12.11.22.20 
Exports (fob) Rs m00000 
Imports (cif) Rs m148160931630 
Fx inflow Rs m01,0411,2581,5581,483 
Fx outflow Rs m148266289418149 
Net fx Rs m-1487759681,1401,334 
INDRAPRASTHA MEDICAL CASH FLOW
From Operations Rs m 643 620 276 477 752 
From Investments Rs m -291 -325 -224 -299 -167 
From Financial Activity Rs m -352 -300 -54 -172 -442 
Net Cashflow Rs m -1 -6 -2 6 143 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 49.4%
Foreign collaborators 1.6%
Indian inst/Mut Fund 1.3%
FIIs 0.5%
ADR/GDR 0.0%
Free float 47.2%
Shareholders 38,169
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Sarita Vihar, Delhi - Mathura Road, New Delhi - 110 076
E-MAIL asinghal@apollohospitals.com WEB www.apollohospdelhi.com
TELEPHONE (011) 2692 5858 FAX (011) 2682 5601
SECTOR HEALTH SERVICES GROUP MISCELLANEOUS
TR AGENT Link Intime India, 44, 2nd Flr., Naraina Indl. Area, Phase I, New Delhi-28
AUDITOR S. C. Vasudeva & Co.
CHM: S. K. Srivastava COMP SEC: A. K. Singhal YEAR OF INC: 1900 BSE CODE: 532150 FV (Rs): 10 DIV YIELD (%): 4.6

Read: INDRAPRASTHA MEDICAL 2018-19 Annual Report Analysis

More Health Services Company Fact Sheets:   SANOFI INDIA  PANACEA BIOTECH  FULFORD INDIA  SUVEN LIFESCIENCES  NOVARTIS  

Compare INDRAPRASTHA MEDICAL With:   SANOFI INDIA  PANACEA BIOTECH  FULFORD INDIA  SUVEN LIFESCIENCES  NOVARTIS  

Compare INDRAPRASTHA MEDICAL With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Surges 1,266 Points; Nifty Ends Above 9,100 Mark(Closing)

Indian share markets witnessed buying interest throughout the day and ended on a strong note.

Views on news

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of INDRAPRASTHA MEDICAL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of INDRAPRASTHA MEDICAL. Also includes updates on the valuation of INDRAPRASTHA MEDICAL.

INDRAPRASTHA MEDICAL Announces Quarterly Results (1QFY20); Net Profit Up 31.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 85 m (up 31.5% YoY). Sales on the other hand came in at Rs 2 bn (up 7.6% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

One Stock that is All Charged Up for the Post Coronavirus Rebound (The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

A Safe Stock to Lockdown Now (The 5 Minute Wrapup)

Apr 2, 2020

The market crashc has made strong, established brands attractive. Here's a stock to make the most of this opportunity...

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak (Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

This Smallcap Tech Firm has Risen to the Coronavirus Challenge (Profit Hunter)

Apr 7, 2020

This smallcap tech firm is all set to emerge stronger from the Coronavirus crisis.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL 8-QTR ANALYSIS

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS